MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1

Immunity

Volumn 33, Issue 1, 2010, Pages 48-59

  Rao, Dinesh S ^a,b   O'Connell, Ryan M ^a   Chaudhuri, Aadel A ^a   Garcia Flores, Yvette ^a   Geiger, Theresa L ^a   Baltimore, David ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cellimmuno; Molimmuno

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; MICRORNA; MICRORNA 34A; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TARGETING;

3' UNTRANSLATED REGIONS; ANIMALS; B-LYMPHOCYTES; BONE MARROW; CELL LINE; CLONING, MOLECULAR; FORKHEAD TRANSCRIPTION FACTORS; HEMATOPOIESIS; HUMANS; MICE; MICE, INBRED C57BL; MICRORNAS; PRECURSOR CELLS, B-LYMPHOID; RADIATION CHIMERA; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77954958215     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2010.06.013     Document Type: Article

References (40)

1. Baltimore D., Boldin M.P., O'Connell R.M., Rao D.S., Taganov K.D. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 2008, 9:839-845.
2. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., Zhai Y., Giordano T.J., Qin Z.S., Moore B.B., et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 2007, 17:1298-1307.
3. Busslinger M. Transcriptional control of early B cell development. Annu. Rev. Immunol. 2004, 22:55-79.
4. Chang T.C., Wentzel E.A., Kent O.A., Ramachandran K., Mullendore M., Lee K.H., Feldmann G., Yamakuchi M., Ferlito M., Lowenstein C.J., et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 2007, 26:745-752.
5. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
6. Chen L., Cui B., Zhang S., Chen G., Croce C.M., Kipps T.J. Association Between the Proficiency of B cell Receptor Signaling and the Relative Expression Levels of ZAP-70, SHIP-1, and Mir-155 in Chronic Lymphocytic Leukemia. Blood 2008, 112:3155.
7. Deshpande A.J., Cusan M., Rawat V.P., Reuter H., Krause A., Pott C., Quintanilla-Martinez L., Kakadia P., Kuchenbauer F., Ahmed F., et al. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell 2006, 10:363-374.
8. Gentner B., Schira G., Giustacchini A., Amendola M., Brown B.D., Ponzoni M., Naldini L. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Methods 2009, 6:63-66.
9. Guidos C.J., Williams C.J., Grandal I., Knowles G., Huang M.T., Danska J.S. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 1996, 10:2038-2054.
10. Hardy R.R., Hayakawa K. B cell development pathways. Annu. Rev. Immunol. 2001, 19:595-621.
11. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
12. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 2010, 17:193-199.
13. Hu H., Wang B., Borde M., Nardone J., Maika S., Allred L., Tucker P.W., Rao A. Foxp1 is an essential transcriptional regulator of B cell development. Nat. Immunol. 2006, 7:819-826.
14. Isken F., Steffen B., Merk S., Dugas M., Markus B., Tidow N., Zühlsdorf M., Illmer T., Thiede C., Berdel W.E., et al. Identification of acute myeloid leukaemia associated microRNA expression patterns. Br. J. Haematol. 2008, 140:153-161.
15. Koralov S.B., Muljo S.A., Galler G.R., Krek A., Chakraborty T., Kanellopoulou C., Jensen K., Cobb B.S., Merkenschlager M., Rajewsky N., Rajewsky K. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008, 132:860-874.
16. Lenz G., Wright G.W., Emre N.C., Kohlhammer H., Dave S.S., Davis R.E., Carty S., Lam L.T., Shaffer A.L., Xiao W., et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc. Natl. Acad. Sci. USA 2008, 105:13520-13525.
17. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
18. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
19. Lois C., Hong E.J., Pease S., Brown E.J., Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002, 295:868-872.
20. Lu L., Osmond D.G. Apoptosis and its modulation during B lymphopoiesis in mouse bone marrow. Immunol. Rev. 2000, 175:158-174.
21. Meffre E., Casellas R., Nussenzweig M.C. Antibody regulation of B cell development. Nat. Immunol. 2000, 1:379-385.
22. Mraz M., Malinova K., Kotaskova J., Pavlova S., Tichy B., Malcikova J., Stano Kozubik K., Smardova J., Brychtova Y., Doubek M., et al. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia 2009, 23:1159-1163.
23. O'Connell R.M., Rao D.S., Chaudhuri A.A., Boldin M.P., Taganov K.D., Nicoll J., Paquette R.L., Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 2008, 205:585-594.
24. O'Connell R.M., Chaudhuri A.A., Rao D.S., Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA 2009, 106:7113-7118.
25. Pedersen I.M., Otero D.C., Kao E., Sedy A., Hother C., Ralfkiaer E., Rickert R.C., Gronbaek K., David M. Onco-Mir-155 Targets SHIP to Regulate TNF-Dependent B cell Lymphoma Growth. Blood 2008, 112:604.
26. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z., Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 2007, 26:731-743.
27. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van Dongen S., Grocock R.J., Das P.P., Miska E.A., et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
28. Shi C., Zhang X., Chen Z., Sulaiman K., Feinberg M.W., Ballantyne C.M., Jain M.K., Simon D.I. Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J. Clin. Invest. 2004, 114:408-418.
29. Shi C., Sakuma M., Mooroka T., Liscoe A., Gao H., Croce K.J., Sharma A., Kaplan D., Greaves D.R., Wang Y., Simon D.I. Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood 2008, 112:4699-4711.
30. Shu W., Yang H., Zhang L., Lu M.M., Morrisey E.E. Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. J. Biol. Chem. 2001, 276:27488-27497.
31. Streubel B., Vinatzer U., Lamprecht A., Raderer M., Chott A. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005, 19:652-658.
32. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J.L., et al. Regulation of the germinal center response by microRNA-155. Science 2007, 316:604-608.
33. Vigorito E., Perks K.L., Abreu-Goodger C., Bunting S., Xiang Z., Kohlhaas S., Das P.P., Miska E.A., Rodriguez A., Bradley A., et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007, 27:847-859.
34. Wang B., Weidenfeld J., Lu M.M., Maika S., Kuziel W.A., Morrisey E.E., Tucker P.W. Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development 2004, 131:4477-4487.
35. Wlodarska I., Veyt E., De Paepe P., Vandenberghe P., Nooijen P., Theate I., Michaux L., Sagaert X., Marynen P., Hagemeijer A., De Wolf-Peeters C. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Leukemia 2005, 19:1299-1305.
36. Xiao C., Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009, 136:26-36.
37. Xiao C., Calado D.P., Galler G., Thai T.H., Patterson H.C., Wang J., Rajewsky N., Bender T.P., Rajewsky K. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131:146-159.
38. Xiao C., Srinivasan L., Calado D.P., Patterson H.C., Zhang B., Wang J., Henderson J.M., Kutok J.L., Rajewsky K. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 2008, 9:405-414.
39. Zenz T., Mohr J., Eldering E., Kater A.P., Bühler A., Kienle D., Winkler D., Dürig J., van Oers M.H., Mertens D., et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 2009, 113:3801-3808.
40. Zhou B., Wang S., Mayr C., Bartel D.P., Lodish H.F. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. USA 2007, 104:7080-7085.